Abiomed plans to file a premarket approval application with the FDA for its Impella heart pump at the close of fiscal year 2014. With the trove of data showing real-world use of the device, which already has 510(k) clearance, CEO Michael Minogue believes Abiomed could get the PMA without having to conduct another trial. "We'd like to be one of the first success stories in the industry that's converted from a 510(k) through the 515 process to PMA," he said.
Abiomed readies PMA application for Impella heart pump
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management